Cite
MLA Citation
Joan How et al.. “A nonrandomized phase I and biomarker trial of regorafenib in advanced myeloid malignancies.” EJHaem, vol. 3, no. 2, 2022, pp. 434–442. http://access.bl.uk/ark:/81055/vdc_100155163644.0x000004
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Joan How et al.. “A nonrandomized phase I and biomarker trial of regorafenib in advanced myeloid malignancies.” EJHaem, vol. 3, no. 2, 2022, pp. 434–442. http://access.bl.uk/ark:/81055/vdc_100155163644.0x000004